Using antisense technology, the effects of suppressed gene expression of the erythroid-specific delta-aminolevulinate (ALA) synthase (ALAS-E) on
heme synthesis, expression of mRNAs encoding an erythroid-specific
transcription factor NF-E2, other
heme pathway
enzymes, and
beta-globin were examined in murine
erythroleukemia (MEL) cells. In MEL cells in which an antisense ALAS-E
RNA was expressed (AS clone), sense ALAS-E
mRNA levels in both untreated and
dimethylsulfoxide (
DMSO)-treated cells were decreased compared with their respective controls.
Heme synthesis in AS clones was decreased in proportion to the suppressed levels of ALAS-E
mRNA. In addition, mRNAs for ALA
dehydratase,
porphobilinogen deaminase,
ferrochelatase (FeC), and
beta-globin were also decreased in AS clones. There was a strong correlation between the level of ALAS-E
mRNA and most of the mRNAs of the
heme pathway
enzymes and
beta-globin. There was a decrease in the
mRNA level of p45, but not of mafK, which are the large and the small subunits of NF-E2, respectively, in AS clones. Treatment of AS cells with
hemin and ALA in the presence of
DMSO partially restored the suppressed
mRNA levels for
beta-globin and FeC and
heme content, respectively. These findings thus indicate that
heme formation, which is determined by the level of ALAS-E, plays an essential role on gene expression of many
proteins necessary for erythroid development.